Background The postresection alpha-fetoprotein (AFP) in cirrhotic patients with
hepatocellular carcinoma (HCC) may predict overall survival (OS) and recurrence beyond …

Liver transplantation (LT) for cirrhotic/Hepatocellular carcinoma (HCC) is associated with
reduced survival in patients with poor histological features. Preoperative levels of …

Objective: To explore the prognostic value of the postsurgical half-life (HL) of serum alpha-
fetoprotein (AFP). Background: There is still a paucity of early surrogate indicators of clinical …

Background Preoperative α-fetoprotein (AFP) levels may have an influence on disease-free
survival (DFS) of patients after liver transplantation for hepatocellular carcinoma (HCC) …

Introduction Although preoperative α-fetoprotein (AFP) has been recognized as an important
tumor marker among patients with hepatocellular carcinoma (HCC), the predictive value of …

Abstract Background and Aim To study the change in serum alpha fetoprotein (AFP) of
patients with recurrent hepatocellular carcinoma (HCC) after curative resection and to …

AIM: To identify the clinical outcomes of hepatocellular carcinoma (HCC) patients with
inconsistent α-fetoprotein (AFP) levels which were initially high and then low at recurrence …

Background The clinical value of alpha-fetoprotein (AFP) in patients with AFP-negative (< 20
ng/ml) hepatocellular carcinoma (HCC) who underwent curative resection remained …

Abstract Background/Aim: Alpha-fetoprotein (AFP) had been used as a prognostic factor in
hepatocellular carcinoma but it was unknown what level of AFP could predict the survival of …

Background Serum alpha-fetoprotein (AFP) is frequently used to predict posthepatectomy
outcomes in patients with hepatocellular carcinoma (HCC), but its predictive value is still not …